Discover the latest advancements in spine and orthopedic robotics, including the first biportal endoscopic fusion and FDA approval for Stryker.

Medtech giants are doubling down on robotic surgery systems as hospitals see fewer complications and shorter stays.

From leadership updates to FDA clearances, here are five key updates from spine and orthopedic medtech companies since Feb. 12.

Stryker reported $6.4 billion in sales and $22,595 million in operating profit for the quarter ending December 31, 2024, ...

Portage, Michigan-based Stryker Corporation (SYK) is a medical technology company that offers innovative products and ...

Stryker is gaining momentum with strong Q4 results, innovative medtech solutions and high-growth market expansion. But, is ...

Stryker’s US spinal implants sale to VB Spine creates growth opportunities for competitors like Medtronic and Globus in the ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

Stryker has agreed to sell its US spinal implants business to the Viscogliosi Brothers. The newly formed company will be ...

According to a report by Mordor Intelligence, the medical devices market has a size of $681.57 billion as of 2025.

Stryker Corp. plans to sell its U.S. spinal implant business to a New York-based family office Viscogliosi Brothers LLC.